These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 23486330)

  • 41. High Molecular Weight ACTH-Precursor Presence in a Metastatic Pancreatic Neuroendocrine Tumor Causing Severe Ectopic Cushing's Syndrome: A Case Report.
    Mehta R; Lam-Chung CE; Hinojosa-Amaya JM; Roldán-Sarmiento P; Guillen-Placencia MF; Villanueva-Rodriguez G; Juarez-Leon OA; Leon-Domínguez J; Grajales-Gómez M; Ventura-Gallegos JL; León-Suárez A; Gómez-Pérez FJ; Cuevas-Ramos D
    Front Endocrinol (Lausanne); 2020; 11():557. PubMed ID: 32903471
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multiple Pathologies Seen on a Single Contrast-Enhanced 18F-FDG PET/CT: Reiteration of Lessons Previously Learned.
    Sharma P; Marangmei C
    Clin Nucl Med; 2015 Sep; 40(9):750-1. PubMed ID: 25706797
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of the application of 18F-FDG and 68Ga-DOTATATE PET/CT in neuroendocrine tumors: A retrospective study.
    Hu X; Li D; Wang R; Wang P; Cai J
    Medicine (Baltimore); 2023 May; 102(19):e33726. PubMed ID: 37171344
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ⁶⁸Ga-DOTANOC PET/CT in patients with carcinoma of unknown primary of neuroendocrine origin.
    Naswa N; Sharma P; Kumar A; Soundararajan R; Kumar R; Malhotra A; Ammini AC; Bal C
    Clin Nucl Med; 2012 Mar; 37(3):245-51. PubMed ID: 22310250
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pancreatic neuroendocrine tumor with ectopic adrenocorticotropin production upon second recurrence.
    Miehle K; Tannapfel A; Lamesch P; Borte G; Schenker E; Kluge R; Ott RA; Wiechmann V; Koch M; Kassahun W; Paschke R; Koch CA
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3731-6. PubMed ID: 15292297
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of combined Ga-DOTANOC and (18)FDG PET/CT in the management of patients with pancreatic neuroendocrine tumors.
    Partelli S; Rinzivillo M; Maurizi A; Panzuto F; Salgarello M; Polenta V; Delle Fave G; Falconi M
    Neuroendocrinology; 2014; 100(4):293-9. PubMed ID: 25301162
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Usefulness of 18F-FDG PET/CT in an unusual case of solid-pseudopapillary pancreatic tumor in childhood with aggressive behavior.
    Treglia G; Caporale N; Rufini V; Callea F; Locatelli F; Giordano A
    Clin Nucl Med; 2013 Jan; 38(1):e35-7. PubMed ID: 23242062
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ectopic ACTH syndrome caused by desmopressin-responsive thymic neuroendocrine tumor.
    Sekiguchi Y; Miyamoto Y; Kasahara I; Hara Y; Tani Y; Doi M; Hirata Y
    Endocr J; 2015; 62(5):441-7. PubMed ID: 25819222
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Whole-Body 68Ga-DOTANOC PET/MRI Versus 68Ga-DOTANOC PET/CT in Patients With Neuroendocrine Tumors: A Prospective Study in 28 Patients.
    Berzaczy D; Giraudo C; Haug AR; Raderer M; Senn D; Karanikas G; Weber M; Mayerhoefer ME
    Clin Nucl Med; 2017 Sep; 42(9):669-674. PubMed ID: 28682844
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metastasis From Clear Cell Renal Cell Carcinoma Mimicking Well-Differentiated Pancreatic Neuroendocrine Tumor at 18F-FDG and 68Ga-DOTATOC PET/CT.
    Guglielmo P; Pesella F; Sartorello A; El Khouzai B; Berti S; Muccioli S; Gregianin M
    Clin Nucl Med; 2022 Jul; 47(7):e498-e499. PubMed ID: 35675141
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ACTH-secreting pancreatic neoplasms associated with Cushing syndrome: clinicopathologic study of 11 cases and review of the literature.
    Maragliano R; Vanoli A; Albarello L; Milione M; Basturk O; Klimstra DS; Wachtel A; Uccella S; Vicari E; Milesi M; Davì MV; Scarpa A; Sessa F; Capella C; La Rosa S
    Am J Surg Pathol; 2015 Mar; 39(3):374-82. PubMed ID: 25353285
    [TBL] [Abstract][Full Text] [Related]  

  • 52. (18)F-FDG PET/CT can be used to detect non-functioning pancreatic neuroendocrine tumors.
    Luo G; Liu Z; Guo M; Jin K; Xiao Z; Liu L; Xu J; Zhang B; Liu C; Huang D; Hu S; Ni Q; Long J; Yu X
    Int J Oncol; 2014 Oct; 45(4):1531-6. PubMed ID: 25096059
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Isolated cardiac metastasis in a patient with neuroendocrine carcinoma of pancreas discovered on ⁶⁸Ga-DOTANOC PET/CT.
    Khangembam BC; Naswa N; Sharma P; Bal C; Malhotra A; Kumar R
    J Nucl Cardiol; 2012 Oct; 19(5):1078-9. PubMed ID: 22538764
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Collision of Solid Pseudopapillary Tumor and Neuroendocrine Tumor of the Pancreas on 18F-FDG PET/CT.
    Yin H; Lv J; Chen L; Xiu Y; Shi H
    Clin Nucl Med; 2021 Apr; 46(4):e214-e215. PubMed ID: 33208615
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The impact of 68Ga-DOTATOC positron emission tomography/computed tomography on the multimodal management of patients with neuroendocrine tumors.
    Frilling A; Sotiropoulos GC; Radtke A; Malago M; Bockisch A; Kuehl H; Li J; Broelsch CE
    Ann Surg; 2010 Nov; 252(5):850-6. PubMed ID: 21037441
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tumor Lysis Syndrome in an Unusual Metastatic Pancreatic Neuroendocrine Tumor with Ectopic ACTH Secretion.
    Shusterman M; Bloomgarden NA; Sotardi ST; Shastri A
    J Gastrointest Cancer; 2016 Dec; 47(4):423-428. PubMed ID: 26271662
    [No Abstract]   [Full Text] [Related]  

  • 57. Detection of Adult Pancreatoblastoma by 18F-FDG and 68Ga-DOTATATE PET/MR.
    Zhou J; Xie J; Pan Y; Zhang Y
    Clin Nucl Med; 2021 Aug; 46(8):671-674. PubMed ID: 33661203
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combined use of 68Ga-DOTATATE and 18F-FDG PET/CT to localize a bronchial carcinoid associated with ectopic ACTH syndrome.
    Därr R; Zöphel K; Eisenhofer G; Abolmaali N; Gastmeier J; Wieczorek K; Jelinek V; Kamvissi V; Bornstein SR; Hofbauer LC
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2207-8. PubMed ID: 22529105
    [No Abstract]   [Full Text] [Related]  

  • 59. 68Ga DOTATATE PET/CT uptake in spinal lesions and MRI correlation on a patient with neuroendocrine tumor: potential pitfalls.
    Klinaki I; Al-Nahhas A; Soneji N; Win Z
    Clin Nucl Med; 2013 Dec; 38(12):e449-53. PubMed ID: 23531732
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dual-Tracer (68Ga-DOTATOC and 18F-FDG-)-PET/CT Scan and G1-G2 Nonfunctioning Pancreatic Neuroendocrine Tumors: A Single-Center Retrospective Evaluation of 124 Nonmetastatic Resected Cases.
    Paiella S; Landoni L; Tebaldi S; Zuffante M; Salgarello M; Cingarlini S; D'Onofrio M; Parisi A; Deiro G; Manfrin E; Bianchi B; Montagnini G; Crinò SF; Bassi C; Salvia R
    Neuroendocrinology; 2022; 112(2):143-152. PubMed ID: 33508821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.